Abstract

As a special biomarker for many nervous system diseases, Glutamate (Glu) plays an important role in clinical application. Therefore, it is of great significance to sense Glu sensitively in aqueous medium or serum. Here, a novel three-fold interpenetration 3D framework of {[Cd (HTCPB) (4,4′-bbib)]·2H2O}n (1) (H3TCPB ​= ​1,3,5-tris(4-carbonylphenyloxy)benzene, 4,4′-bbib ​= ​4,4′-bis(benzoimidazo-1-yl)biphenyl) (1) has been successfully synthesized and characterized by single-crystal X-Ray diffraction (SCXRD), X-ray powder diffraction analyses (PXRD), thermogravimetric (TG) and X-ray photoelectron spectroscopy (XPS). Stability experiments show that 1 has excellent water and thermal stability. And luminescence experiments demonstrated that 1 can selectively and sensitively sense Glu in aqueous solution with the limit of detection (LOD) being 1.15 ​× ​10-7 ​M. Meanwhile, the detection concentration of 1 towards Glu in serum is 4.31 ​× ​10-5 ​M, which is far lower than that of Glu (4 ​× ​10-4 ​M) in the blood of patients with glioma. In addition, the interaction between carboxylate groups (-COOH) of H3TCPB ligands in 1 and amino-groups (−NH2) of Glu is mainly responsible for the turn-on phenomenon of 1. These results provide a platform of 1 for sensing Glu in clinical application.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.